Plasticsurgerypractice iconPlasticsurgerypracticeSep 23, 2026 ~3 min source read

Allergan Aesthetics launches AA Signature consultation framework in the US, starting with SKIN360

A structured consultation program designed to standardize multimodal facial assessment and connect clinical evaluations to specific product-based treatment pathways, beginning with skin hydration and quality.

Allergan Aesthetics Launches AA Signature Consultation Program in the US

Share this story

Send the public story page.

Useful takeaways from this story.

AA Signature: SKIN360 is the first protocol in a planned series, focused on skin smoothness and hydration and using three Allergan-linked products.

Allergan Aesthetics cites practice data showing multimodal planning correlates with higher patient retention and increased patient willingness to proceed with multi-product regimens.

The company warns the safety and efficacy of the three SKIN360 products used together have not been evaluated.

# Aesthetics announced

Allergan Aesthetics, the AbbVie aesthetics business, has launched AA Signature in the US: a structured consultation framework to guide health care providers through multimodal facial assessments and individualized treatment planning. The rollout begins with AA Signature: SKIN360, described as the first of several planned protocols.

# What SKIN360 covers

SKIN360 targets patients who want smoother, more hydrated skin across multiple facial and related anatomical regions. The protocol directs providers to assess three modalities together as part of a consultation pathway:

  • Skinvive by Juvederm: an intradermal microdroplet injection indicated to improve cheek smoothness and hydration.
  • SkinMedica HA5 Hydra Collagen Hydrator with Vegan Collagen: a topical hydrator aimed at supporting long-term skin health and visible plumping.
  • Botox Cosmetic (onabotulinumtoxinA): an FDA-approved injectable for temporarily improving certain facial lines and platysma bands.

Allergan Aesthetics notes that the safety and efficacy of combining these three products have not been evaluated.

# Why Allergan is promoting a protocol approach

  • Practices that adopt multimodal treatment planning reportedly achieve 68% higher patient retention compared with practices treating a single concern.
  • A cited survey shows 96% of patients expressed interest in receiving a "comprehensive" consultation.
  • A separate category-wide study found that eight out of 10 patients chose to proceed with treatment after a comprehensive assessment that recommended two or more in-office procedures or products.

These findings are used by Allergan Aesthetics to argue that structured, multimodal consultations can increase patient engagement and conversion to multi-product regimens.

# Clinical and practice implications

The company plans to expand AA Signature with protocols that will address tissue lift, structural volume, skin firmness, and facial definition through 2027. Practices should note the explicit company statement that combined use of the three SKIN360 products has not been studied for safety or efficacy.

# What this means for practices and patients

For practices: AA Signature provides a repeatable consultation framework and educational resources tied to specific product options. The program is intended to systematize how providers evaluate multiple facial concerns in a single consultation.

For patients: Allergan frames the approach as a pathway to more comprehensive, multimodal treatment plans. The company's cited data indicate strong patient interest in comprehensive assessments and a higher likelihood of proceeding with multi-procedure plans after such consultations.

# Next steps announced by Allergan

Allergan Aesthetics will continue to release additional AA Signature protocols through 2027, expanding beyond skin quality into areas such as lift and volume. Clinics interested in adopting the framework will likely receive protocol materials and access to Allergan Medical Institute resources as part of the rollout.

More context around this story.

Kevinmd iconKevinmdSep 11, 2026

Patient experience in urgent care is a workflow issue too

When I joined OrthoIllinois in 2022 and took on leadership responsibilities at Injury Express, our orthopedic urgent care practice was already delivering high-quality clinical care. But as I became more involved in reviewing our patient-experience data, I noticed that some of our biggest opportunities for improvement h

Kevinmd iconKevinmdSep 10, 2026

Clinical trial retention starts with a kind conversation

Patients may not remember every lab draw, procedure, or study visit. But they will remember how they felt. One of the greatest privileges of working in clinical research for more than twenty years has been meeting extraordinary people. Clinical research is often associated with science, data, and innovation. Those elem

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app